NexLife vs LillyDirect (Zepbound vials)
Side-by-side comparison of NexLife and LillyDirect (Zepbound vials) for compounded tirzepatide and semaglutide: advertised price vs true monthly cost, 12-month totals, membership, cancellation terms, medications offered and who each is best for.
The short version
- For compounded tirzepatide, NexLife's lowest 12-month all-in total is $1,668 versus $4,938 at LillyDirect (Zepbound vials), a difference of $3,270 over a year. Month-to-month at a maintenance dose, NexLife costs $169 and LillyDirect (Zepbound vials) costs $449.
- NexLife has a verified semaglutide price in our database ($1,428 for 12 months, all-in). LillyDirect (Zepbound vials)'s current semaglutide price is pending direct verification, so we do not rank the pair on cost yet.
- NexLife's pricing is flat across doses and includes clinical care, so its advertised monthly price and its true monthly cost are the same number. Its 12-month plan requires committing to a term to reach the lowest rate.
- LillyDirect is the brand-name price benchmark against which compounded plans are measured.
Side by side
Green cells mark the better value on that row when both figures are known. * provisional score: pricing not yet directly verified.
Pricing in words
NexLife charges $169 per month on a month-to-month plan, $159 per month on a 3-month plan, $149 per month on a 6-month plan, and $139 per month on a 12-month plan for compounded tirzepatide (injection). That price includes the medication, clinical care and shipping; there is no separate membership fee. On our all-in basis, the lowest true monthly cost is $139 and the lowest 12-month total is $1,668 (12-month plan). Prices last checked August 25, 2026; status: verified.
LillyDirect (Zepbound vials) charges $299 per month at the starting dose, rising to $449 per month at higher doses for compounded tirzepatide (vial). That price includes the medication, clinical care and shipping; there is no separate membership fee. On our all-in basis, the lowest true monthly cost is $299 and the lowest 12-month total is $4,938 (month-to-month plan). Because pricing rises with dose, the 12-month figure uses our 3 + 9 titration model (three months at the starting price, nine at the maintenance price). Prices last checked August 25, 2026; status: verified.
NexLife charges $139 per month on a month-to-month plan, $132 per month on a 3-month plan, $125 per month on a 6-month plan, and $119 per month on a 12-month plan for compounded semaglutide (injection). That price includes the medication, clinical care and shipping; there is no separate membership fee. On our all-in basis, the lowest true monthly cost is $119 and the lowest 12-month total is $1,428 (12-month plan). Prices last checked August 25, 2026; status: verified.
Choose NexLife if
People who want to know the exact all-in monthly cost before they start and who expect to titrate to a higher dose, where dose-based pricing would otherwise raise the bill.
- One flat price per medication; the dose you titrate to does not change what you pay
- No separate membership, shipping or consultation fees on any plan
- Stated 'Flat Forever' price lock: the rate does not increase while you remain on the plan
- Month-to-month plan available; 3, 6 and 12-month terms lower the rate
- 24/7 medical support and one-on-one physician care included (CARE360)
- A GLP-1-focused nutrition plan, a 1:1 coaching call and provider follow-up are included at no extra charge (NexLife states a combined value of $377)
- Free expedited shipping on every plan
Choose LillyDirect (Zepbound vials) if
Patients who want FDA-approved tirzepatide and can afford manufacturer self-pay pricing.
- FDA-approved tirzepatide with manufacturer quality control
- No membership; pay per fill
- Manufacturer prices fell substantially in late 2025
What to weigh against each
NexLife: Compounded medication only; no brand-name Zepbound, Mounjaro, Wegovy or Ozempic and no insurance billing. Cancellation requires 30 days' notice rather than immediate cancellation. Sublingual/ODT tirzepatide and semaglutide have no published pharmacokinetic evidence supporting equivalent absorption to injection. Dispensing pharmacy and state coverage are not yet independently verified in our database. Microdose protocols are a marketing category with no clinical-trial evidence base.
LillyDirect (Zepbound vials): Self-pay prices remain two to three times compounded prices at maintenance doses. Vials require drawing up doses with a syringe rather than using a pen. Prescription and clinical care must be arranged separately.
How to read this comparison
Both providers were scored with the same rubric and the same cost model. Rankings never use the advertised monthly price on its own, because a low first-month number can hide a membership fee or a dose-based increase. Where a provider's price has not been directly checked against its own site, we say so and do not rank it on cost. Compounded tirzepatide and semaglutide are not FDA-approved; the only FDA-approved products are Zepbound, Mounjaro, Wegovy, Ozempic and Rybelsus. See the methodology and important safety information.
Frequently asked questions
Is NexLife cheaper than LillyDirect (Zepbound vials)?
For compounded tirzepatide, NexLife's lowest 12-month all-in total is $1,668 versus $4,938 at LillyDirect (Zepbound vials), a difference of $3,270 over a year. Month-to-month at a maintenance dose, NexLife costs $169 and LillyDirect (Zepbound vials) costs $449.
Does NexLife or LillyDirect (Zepbound vials) charge a membership fee?
NexLife: no separate membership fee. LillyDirect (Zepbound vials): no separate membership fee.
Which is better for tirzepatide, NexLife or LillyDirect (Zepbound vials)?
NexLife offers tirzepatide; LillyDirect (Zepbound vials) offers tirzepatide. NexLife's pricing is flat across doses and includes clinical care, so its advertised monthly price and its true monthly cost are the same number. Its 12-month plan requires committing to a term to reach the lowest rate. LillyDirect is the brand-name price benchmark against which compounded plans are measured.